News
Launching the ORBI Study
Trial Deck is proud to be supporting the soon-to-launch ORBI Study, led by Dr. Rona Morris-Moss at King’s College London.
12 May 2025
12 May 2025
Trial Deck is proud to be supporting the soon-to-launch ORBI Study, led by Dr. Rona Morris-Moss at King’s College London.
As the Clinical Trial Management System for the study, Trial Deck has been involved in every stage of the study set up. The study design has been carefully mapped using the Trial Deck Builder, enabling a clear, auditable flow from recruitment through to data collection. Designated recruitment channels have also been developed in-platform to support targeted outreach and streamlined enrolment.
A core feature of the project is the implementation of bespoke, minimised randomisation tailored specifically to the ORBI study’s needs. The randomisation algorithm was developed in close collaboration with the study team and allows for repeated validation by statisticians to ensure full compliance prior to launch.
We’re delighted to be working alongside King’s College London on this project and look forward to a strong and productive partnership in the months ahead.
Trial Deck is proud to be supporting the soon-to-launch ORBI Study, led by Dr. Rona Morris-Moss at King’s College London.
As the Clinical Trial Management System for the study, Trial Deck has been involved in every stage of the study set up. The study design has been carefully mapped using the Trial Deck Builder, enabling a clear, auditable flow from recruitment through to data collection. Designated recruitment channels have also been developed in-platform to support targeted outreach and streamlined enrolment.
A core feature of the project is the implementation of bespoke, minimised randomisation tailored specifically to the ORBI study’s needs. The randomisation algorithm was developed in close collaboration with the study team and allows for repeated validation by statisticians to ensure full compliance prior to launch.
We’re delighted to be working alongside King’s College London on this project and look forward to a strong and productive partnership in the months ahead.
Trial Deck is proud to be supporting the soon-to-launch ORBI Study, led by Dr. Rona Morris-Moss at King’s College London.
As the Clinical Trial Management System for the study, Trial Deck has been involved in every stage of the study set up. The study design has been carefully mapped using the Trial Deck Builder, enabling a clear, auditable flow from recruitment through to data collection. Designated recruitment channels have also been developed in-platform to support targeted outreach and streamlined enrolment.
A core feature of the project is the implementation of bespoke, minimised randomisation tailored specifically to the ORBI study’s needs. The randomisation algorithm was developed in close collaboration with the study team and allows for repeated validation by statisticians to ensure full compliance prior to launch.
We’re delighted to be working alongside King’s College London on this project and look forward to a strong and productive partnership in the months ahead.
